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doi:10.1016/j.jfma.2011.11.029Background/Purpose: Accurate and timely diagnosis is vital for the clinical management of
influenza. A 2009 pandemic influenza A (H1N1)-specific enzyme-linked immunosorbent assay
(ELISA) was tested with selected clinical samples.
Methods: A selection of 90 throat swab samples with various viral loads of 2009 pandemic influ-
enza A (H1N1) were tested.
Results: Using the reverse transcriptase polymerase chain reaction as a gold standard, the
overall sensitivity (0.57) was higher than that of the QuickVue Influenza AþB Test (0.43).
The specificity of the ELISA was 1.0 using the selected sample set. The positive and negative
predictive values were 1 and 0.4, respectively.
Conclusion: The ELISA is an easy to perform, highly specific, and fairly sensitive diagnostic tool
for the 2009 pandemic influenza A (H1N1) virus infections. A strong correlation was found
between viral load and specificity.
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Being genetically unstable and highly contagious, and
having short incubation periods, influenza virus often
causes flu outbreaks. Rapid and correct recognition of
influenza infection is very important in terms of patient& Formosan Medical Association. All rights reserved.
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remains the gold standard for the microbiological diagnosis
of influenza infection, and the reverse transcriptase poly-
merase chain reaction (RT-PCR) is another recommended
diagnostic method with high sensitivity and specificity.
However, viral culture is time-consuming, and RT-PCR is
expensive; in addition, neither of these two methods is
universally available. Other rapid, easy to perform, and
accurate diagnostic tools are therefore needed.
Several rapid influenza diagnostic kits are already
available commercially.1e3 For example, the QuickVue
Influenza AþB Test (Quidel, San Diego, CA, USA), which is
an enzyme-linked immunosorbent assay (ELISA)-based kit
and detects both influenza virus A and influenza virus B, has
shown a sensitivity of 0.63 and a specificity of 0.96 with the
2009 pandemic influenza A (H1N1) infection.4 Most of these
rapid tests use monoclonal antibodies against nucleopro-
tein encoded by influenza A viruses.5
In this study, we tested a new 2009 pandemic influenza A
(H1N1)-specific ELISA6 designed and manufactured by Xia-
men University, China, on human samples. Monoclonal
antibody against hemagglutinin, instead of nucleoprotein,
was used in this assay. Samples from patients with an
influenza-like illness, some of whom had been confirmed to
have 2009 pandemic influenza A (H1N1) infections, were
tested. The QuickVue Influenza AþB Test was used at the
same time for comparison.
Methods
Patients and specimens
There was an epidemic of swine-origin influenza A (H1N1)
in Taiwan from July to the end of 2009. During mid-August
to late November of 2009, we consecutively collected
samples from 970 children with an influenza-like illness in
the Department of Pediatrics of the National Taiwan
University Hospital. A nasopharyngeal swab and two
separate throat swabs were collected from each patient.
The nasopharyngeal swab was tested for influenza antigen
using the QuickVue kit. The throat swabs were stored in
Dulbecco’s Modified Eagle’s Medium supplemented with
antibiotics. One of the throat swabs was sent to the labo-
ratory for virus culture. The medium harboring the other
throat swab was vigorously vortexed and frozen for later
use for real-time RT-PCR.
In order to understand the usefulness of the new 2009
pandemic influenza A (H1N1) virus-specific ELISA kit, we
tested it against a variety of stored throat swab samples.
First, we selected 70 RT-PCR-confirmed 2009 pandemic
influenza A (H1N1) virus-positive samples with different
levels of viral load. Thirty of these samples were known to
be positive by QuickVue Test as well. The other 40 samples
were negative using the QuickVue Test.
Second, we tested 20 samples positive for influenza A on
QuickVue testing but negative for 2009 pandemic influenza
A (H1N1) virus by RT-PCR. These included three samples
positive for seasonal influenza A (H3N2) and one positive for
seasonal influenza A (H1N1). The remaining 16 samples
were positive by QuickVue Test but negative in terms of the
above-mentioned influenza viruses by RT-PCR.ELISA for 2009 pandemic influenza A (H1N1)6
A solid-phase sandwich ELISA kit was developed and
provided by the Xiamen University, China. This utilizes
a monoclonal antibody specific for 2009 pandemic influenza
A (H1N1) virus HA protein, which has been precoated onto
96-well ELISA plates. The assay was carried out following
a standard ELISA protocol and the manufacturer’s instruc-
tions. In short, 100 mL of samples in a sample dilution buffer
were added to the wells. The plates were sealed with
adhesive tape and incubated for 2 hours at 37C. The wells
were washed five times, and a horseradish peroxidase-
conjugated rabbit anti-hemagglutinin polyclonal antibody
was then added before incubating for 30 minutes, producing
an antibodyeantigeneantibody “sandwich.” The wells were
again washed, and then tetramethylbenzidine substrate
solution was loaded.
Stop solution was added to end the enzyme reaction,
and the optical absorbances of the microwell were read at
450 nm within 5 minutes. Optical densities less than 0.05
were recorded as 0.05. The mean optical densities of the
blanks times 2.1 were used as the cut-off values for positive
results. All the tests were duplicated. The sensitivity and
specificity of the ELISA were reported to be 93.7% and 99.1%
according to the manufacturer’s data sheet.RT-PCR for influenza A viruses
Total RNA was isolated from 100 mL of medium harboring
throat swab samples using the MagNA Pure LC Total Nucleic
Acid Isolation Kit (Roche Inc., Mannheim, Germany). Real-
time RT-PCR was performed with a LightCycler RNA Master
System (Roche Inc.) with 2.5 mL RNA in a 10 mL reaction
mixture. The primers, forward 50-CATTTGAAAGGTTTGAGA-
TATTCCC-30 and reverse 50-GGACATGGAGCCGTTACACC-30,
and probe, FAM-ACAAGTTCATGGCCCAATCATGACTCG-BHQ1,
were designed for the detection and quantitation of 2009
pandemic influenzaA(H1N1)hemagglutinin (product positions
379e460).7 Primer set, forward 50-GGCACACTGGAGTTTAA-
CAATG-30 and reverse 50-GTGGGTCAACCAATTCAATCTAC-30,
and probe 50-FAM-ATTGGACTGGAGTCACTCAGAATGGA-BHQ1
were used to detect seasonal influenza A (H3N2). Roche
LightCycler RNA Amplification Kit SYBR Green I was used to
detect seasonal influenza A (H1N1) with the primer set of
forward 50-ATGCGAATTACTGATTTCCAAGGA-30 and reverse
50-ATGCTGACACTCCGGTTACGGTG-30.Statistical analysis
We calculated the sensitivity, specificity and positive and
negative predictive values (PPV and NPV, respectively) of
the 2009 pandemic influenza A (H1N1) ELISA using RT-PCR
as the gold standards.
A comparison of the sensitivity of the tests for different
viral loads was made using the Chi-square test. Pearson
correlation was used to measure the relationship between
the viral loads and test sensitivities. Data analysis was
performed using SPSS, version 15.0 (SPSS Inc., Chicago, IL,
USA). A p value <0.05 was considered to be statistically
significant.
Table 1 Results of QuickVue Influenza AþB Test and 2009 pandemic influenza A (H1N1) enzyme-linked immunosorbent assay
(ELISA) according to the reverse transcriptase polymerase chain reaction (RT-PCR) results for throat swab samples from 90
patients.
Influenza RT-PCR Sample no. QuickVue Influenza AþB
Test
2009 influenza A(H1N1)
ELISA
Positive Negative Positive Negative
2009 A (H1N1) postive 70 30 40 40 30
2009 A (H1N1) negative 20 20 0 0 20
Seasonal A(H3N2)a 3 3 0 0 3
Seasonal A(H1N1)a 1 1 0 0 1
None of the abovea 16 16 0 0 16
Total 90 50 40 40 50
a Distributions of RT-PCR results for seasonal influenza A viruses in the 2009 influenza A (H1N1)-negative samples.
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A total of 90 samples were tested; 70 of these were positive
for 2009 influenza A (H1N1) virus by the ELISA kit. The
distribution of 2009 pandemic influenza A (H1N1) ELISA
results, together with the results of QuickVue Test, in these
selected samples are shown according to RT-PCR results in
Table 1. Using RT-PCR as the gold standard, ELISA had
a higher sensitivity (57%) than the QuickVue Test (43%) for
this selected sample set. None of the samples negative for
2009 pandemic influenza A (H1N1) virus by RT-PCR were
positive on ELISA, indicating a specificity of 100%. The PPV
and NPV of the ELISA were 100% and 40%, respectively.
The sensitivities of both the ELISA and QuickVue Tests
were significantly different for samples with different viral
loads. Sample numbers of various viral loads, together with
the sensitivities of the QuickVue Test and ELISA at different
viral loads and as a whole, are shown in Table 2. The
sensitivities of the tests were as high as 100% at high viral
loads and decreased as the viral load fell to lower than 105
(ELISA) or 107 (QuickVue) (Fig. 1). There were good corre-
lations between viral load and the sensitivity of the ELISA or
QuickVue Test (Pearson correlation coefficient 0.866 and
0.987, respectively). In certain viral load ranges, the ELISA
tended to have higher sensitivity than the QuickVue TestTable 2 Sample numbers and test results of 2009 pandemic infl
and QuickVue Influenza AþB Test according to viral load.
Logarithm of influenza
A (H1N1) virus load
(log10 copies/mL)
Sample
number
QuickVue Influenza A
No. positive Sensitivity
9 1 1 100
8 3 3 100
7 12 9 75
6 10 6 60
5 16 7 44
4 23 4 17
3 5 0 0
All 70 30 43
*Comparisons of sensitivities were made among groups of different vi(Fig. 1), but the differences were not statistically
significant.
When plotted according to the ELISA results, the viral
loads could be separated into two distinct groups of
patients with positive and with negative ELISA results
(Fig. 2). The cut-off value of viral load for the ELSIA was
between 105 and 106. All samples with viral loads higher
than 106 tested positively using ELISA. Meanwhile, the
distribution of viral loads overlapped greatly in samples
testing positive and negative on the QuickVue Test. It was
impossible to draw a line to separate these two groups
(Fig. 2).Discussion
The ELISA evaluated in this study was found to be an easy to
perform, highly specific and reasonably sensitive diagnostic
tool for 2009 pandemic influenza A (H1N1) virus infections.
The specificity of the ELISA is remarkably high. None of the
samples negative for 2009 pandemic influenza A (H1N1) on
RT-PCR tested positive by ELISA. Unlike the QuickVue Test,
which is a screening test designed for all influenza A and B
viruses, the ELISA tested in this study was designed
specifically for 2009 pandemic influenza A (H1N1) virus.uenza A (H1N1) enzyme-linked immunosorbent assay (ELISA)
þB Test 2009 pandemic influenza A (H1N1) ELISA
(%) p* No. positive Sensitivity (%) p*
0.0015 1 100 <0.0001
3 100
12 100
10 100
12 75
2 9
0 0
40 57
ral loads.
Figure 1 Sensitivities of 2009 pandemic influenza A (H1N1)
enzyme-linked immunosorbent assay and the QuickVue Influ-
enza AþB Test at various viral loads.
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tested negative using the ELISA. On the other hand, the
sensitivity of the ELISA is comparable to or even higher than
that of the QuickVue Test, which was reported to have
sensitivities of 51% for 2009 pandemic influenza A (H1N1),
63% for H1N1 seasonal influenza, and 31% for H3N2 seasonal
influenza.8
The sensitivity found in the current study could be an
underestimate because we intentionally used samples of
differing viral loads, including low loads. In clinical
settings, patients with 2009 pandemic influenza A (H1N1)
virus infections had a mean initial viral load of
1.84  108 copies/mL.9 The mean viral load peaked soon
after onset of the symptoms and then decreased gradually
to a range of 105 around the fifth day after onset.9 In such
circumstances, the sensitivity of the current ELISA in clin-
ical settings could be much higher than 57%, and probably
higher than 80%, because most clinical samples from
symptomatic patients would have viral loads higher than
105, which would be detectable using the ELISA.
The PPV of the ELISA was also extraordinarily high
(100%). According to our results, once the sample had
tested positive using ELISA, there was no false positivity.Figure 2 Distribution of viral loads of 2009 pandemic influenza A
linked immunosorbent assay and QuickVue Influenza AþB Test resuHowever, it should be borne in mind that our study used
a selected samples set in which 2009 pandemic influenza A
(H1N1) was highly prevalent (70/90, 77.8%), and the PPV
will be lower when disease prevalence is low. Cautions
should be taken while making a diagnosis using this ELISA
beyond the influenza season as false positives may appear.
There is a good correlation between the viral load and
the sensitivity of the ELISA or QuickVue Test. The higher the
viral load, the higher the sensitivity will be (Table 1 and
Fig. 1). These findings confirmed viral loads in the samples
to be a major determinant of the sensitivity of the tests.
This factor might also underlie the clinical observation that
sensitivities of influenza rapid immunoassays were lower in
the early stages of the infection,10 as viral loads are lower
in the early stages of the infection. In patients with milder
symptoms, viral loads could also be low, and lower sensi-
tivities of the tests are expected. An appropriate sampling
procedure is also important in this regard: inadequate
sampling will result in low viral load and reduced
sensitivity.
There are always limitations of sensitivity for any influ-
enza diagnostic test. Clinicians’ clinical decisions should
not be based on laboratory tests alone when managing
patients with influenza-like illnesses; clinical diagnosis is
also very important. Some authorities have successfully
developed clinical syndrome approaches that are comple-
mentary to the diagnostic tests.11
The 2009 pandemic influenza A (H1N1) ELISA developed
by Xiamen University and tested in this study is a useful
assay with an acceptable sensitivity and an extremely high
specificity. Higher viral loads are associated with higher
sensitivities. This ELISA is a good alternative diagnostic tool
for 2009 pandemic influenza A (H1N1) infection, especially
in outbreaks when case numbers are large and RT-PCR is not
available. Surveillance of influenza activities around the
world has shown that 2009 novel influenza A (H1N1) virus
has not disappeared since the 2009e2010 pandemic12; it
has become a seasonal influenza and will continue to
circulate in communities around the world for many years.
A reliable diagnostic test will still be helpful here. In
addition, the technique could be applied for diagnosis of
any other influenza strain.(H1N1) according to 2009 pandemic influenza A (H1N1) enzyme-
lts in throat swab samples from 70 patients.
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